Dimensional Fund Advisors LP's 5.1% Ownership in Avanos Medical Inc
2025-10-09SEC Filing  SCHEDULE 13G/A  (0000354204-25-001265)
Dimensional Fund Advisors LP has filed a Schedule 13G/A amendment, disclosing a 5.1% beneficial ownership in Avanos Medical Inc. The filing indicates that Dimensional Fund Advisors LP, an investment adviser, manages funds that hold 2,352,634 shares of Avanos Medical Inc's common stock. Dimensional Fund Advisors LP disclaims beneficial ownership of these shares, stating that they are held by the funds it manages. The filing also notes that no single fund exceeds a 5% ownership stake in the company. The amendment was signed by Selwyn Notelovitz, Global Chief Compliance Officer, on October 9, 2025.
Tickers mentioned in this filing:AVNS
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1606498/0000354204-25-001265.txt